Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-24-019650
Filing Date
2024-04-12
Accepted
2024-04-12 17:00:35
Documents
4
Period of Report
2024-05-17

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20017192x1_pre14a.htm PRE 14A 804850
2 logo_atai.jpg GRAPHIC 43339
3 ny20017192x1_pc01.jpg GRAPHIC 740845
4 ny20017192x1_pc02.jpg GRAPHIC 957600
  Complete submission text file 0001140361-24-019650.txt   3204030
Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40493 | Film No.: 24842203
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)